Surrogacy in Kanpur

Gestational surrogacy involves a woman carrying a pregnancy after an embryo created through IVF is transferred to her uterus. The woman carrying the pregnancy does not provide the egg for that embryo. Whose eggs and sperm may lawfully be used depends on the applicable rules and the circumstances of the intended parent or parents. Surrogacy is therefore not simply another embryo transfer option: it involves a separate person accepting pregnancy-related risks, alongside legal requirements governing whether the arrangement can proceed.

People may explore surrogacy after learning that they cannot carry a pregnancy or that doing so could seriously affect their health. Even then, an appropriate medical indication does not automatically mean legal eligibility. The process requires consideration of the intended family's circumstances, the surrogate's health and voluntary consent, and the future child's welfare. Information on this page should help structure those discussions, rather than suggest that a suitable surrogate, approved arrangement or pregnancy outcome can be assured.

Surrogacy in India is governed by the Surrogacy (Regulation) Act, 2021, its rules and applicable amendments. Only legally permitted altruistic surrogacy is allowed; commercial arrangements are prohibited. Altruistic surrogacy does not mean that pregnancy has no expenses. Permitted medical expenses and insurance requirements must be handled within the law, without prohibited payment or inducement. Statutory eligibility, required certificates and approvals must be established through the designated authorities, and surrogacy procedures require a centre registered for that purpose.

Rules concerning family circumstances, medical indications, donor gametes and documentation should be checked against the current legal position rather than assumed from online summaries. A treating doctor can assess medical issues, but cannot replace the determination of the relevant statutory authority. Where legal interpretation is needed, seek qualified independent advice. PRAVI's availability for an information consultation must not be taken as evidence of surrogacy registration, an approved programme, surrogate provision or a legal paperwork service.

• Ask which statutory authority must assess your circumstances and issue the required certificates.
• Confirm the treating centre's applicable registration before agreeing to any surrogacy procedure.
• Do not enter payment, matching or treatment arrangements on the basis of informal assurances.

A medical discussion may be appropriate for someone born without a uterus, someone who has had the uterus removed, or someone with a uterine condition that prevents carrying a pregnancy. It may also be relevant when a serious medical condition makes pregnancy unsafe. The assessment depends on the specific diagnosis and may require an opinion from a physician or another specialist familiar with the condition. These examples describe possible clinical reasons for discussion, not automatic qualification under Indian law.

Repeated unsuccessful IVF treatment alone does not establish that surrogacy is the right next step. Clinicians should review embryo-related factors, uterine findings, previous transfer details and other possible explanations before attributing failure to an inability to carry a pregnancy. Surrogacy may not be appropriate when a safer, reasonable alternative exists, when the underlying issue is unlikely to be addressed by another person carrying the pregnancy, or when statutory criteria are not met. Existing embryos and willingness to proceed do not override those limits.

Evaluation usually begins with medical records, relevant surgery reports, previous fertility investigations and details of earlier pregnancies or IVF cycles. Clinicians may review imaging, infection screening and general health, with additional tests guided by the clinical history. If egg collection is being considered, ovarian reserve assessment can help estimate likely response to stimulation. AMH reflects aspects of egg quantity and treatment response; it does not measure egg quality or establish certainty about natural pregnancy, embryo development or a future birth.

The source of eggs and sperm requires both clinical discussion and legal verification. Do not assume that donor eggs, donor sperm or previously created embryos can be used in every surrogacy arrangement. Applicable requirements under surrogacy law and the ART Act and Rules must be checked, with donor services accessed through registered ART banks where legally permitted. A prospective surrogate also needs medical assessment, appropriate screening and counselling within the lawful pathway. Screening reduces some uncertainties but cannot certify a risk-free pregnancy or guarantee a healthy baby.

Where legal approvals and clinical suitability are established, embryo creation generally follows an IVF pathway. Eggs are collected after ovarian stimulation and fertilised with sperm in a laboratory. ICSI, where a sperm is injected into an egg, may be recommended for specific indications, but is not routinely better for everyone. Embryos are assessed as they develop, and storage may be needed while the approved pathway is completed. Some eggs or embryos may not survive freezing and warming; storage does not promise unchanged quality or pregnancy.

Before transfer, the surrogate's uterine lining is assessed and prepared using a clinically appropriate approach. An embryo is placed into the uterus through a thin catheter, followed by prescribed support and a planned pregnancy test. The number of embryos transferred requires careful discussion because multiple pregnancy carries additional risks. Fertilisation, embryo development and transfer do not guarantee implantation or live birth. These are general descriptions, not confirmation of PRAVI's surrogacy services; the actual centre, availability, protocol and consent requirements must be verified before treatment.

The person providing eggs faces risks associated with stimulation and egg retrieval, including ovarian hyperstimulation, bleeding, infection and sedation-related complications. The surrogate faces pregnancy risks even when screening is reassuring. These include miscarriage, ectopic pregnancy, high blood pressure, gestational diabetes, bleeding, operative delivery and complications after birth. Multiple pregnancy can increase risks for both the surrogate and babies. Any consent discussion should distinguish the risks of fertility procedures from those that develop during pregnancy, delivery and recovery.

Emotional preparation is equally important. Intended parents may experience uncertainty, loss of control or grief after unsuccessful treatment, while the surrogate may need support with physical demands, family pressures and recovery. Consent must be voluntary and informed, without coercion or prohibited financial inducement. Counselling should allow concerns to be raised privately, not only in a joint meeting. Discuss how decisions about complications, prenatal findings and pregnancy management will be handled within the law, while respecting the surrogate's autonomy and consent.

• Clarify access to independent counselling and opportunities to discuss concerns privately.
• Ask how disagreements, unexpected findings and changes in medical circumstances would be addressed.
• Understand permitted expenses, required insurance and responsibility for care before proceeding.

After embryo transfer, the treating team provides instructions about medicines, pregnancy testing and symptoms requiring assessment. Testing too early can produce confusing results. A positive test needs follow-up, usually including ultrasound at an appropriate stage to confirm the pregnancy's location and development. Severe abdominal pain, heavy bleeding, fainting or breathing difficulty require urgent medical attention. If transfer does not result in pregnancy, the team should review the cycle without assuming that repeating treatment or changing the surrogate will resolve the problem.

A continuing pregnancy requires antenatal care and appropriate prenatal counselling and screening; IVF conception does not remove these needs. Responsibilities for obstetric appointments, urgent care, delivery and postnatal follow-up should be established before treatment, rather than presumed to be bundled with fertility care. The surrogate needs recovery support and review of physical and emotional wellbeing after birth or pregnancy loss. The intended family also needs clear guidance from the relevant authorities on required documentation and the child's legal status under the approved arrangement.

For a consultation at PRAVI IVF in Kanpur, bring relevant medical summaries, operation notes, specialist opinions and records of previous fertility treatment. If embryos are already stored, bring the available embryology and storage documentation. It can help to write down why surrogacy has been suggested and which alternatives have been discussed. Ask whether further medical assessment is needed to establish the reason pregnancy cannot safely or feasibly be carried, rather than starting with assumptions about eligibility.

Confirm what PRAVI can actually provide for your circumstances: an information discussion, medical assessment or another specifically explained service. This page does not establish that PRAVI is registered to perform surrogacy, provides surrogates, arranges legal documentation or offers bundled pregnancy care. Ask who must determine statutory eligibility, which approvals are required and where any legally permitted procedures would take place. A useful consultation should leave you with clear medical questions, realistic limitations and an understanding of what remains to be verified before any commitment.